AKYA · Categories · Form 4
AKYA - SEC Form 4 insider transactions
Akoya BioSciences Inc. (AKYA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for AKYA
- Director Mendel Scott disposed of 28,500 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Chief Business Officer Ramachandran Niro Ph.D acquired 62,566 shares, covered exercise/tax liability with 42,148 shares and disposed of 282,555 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- President and CEO Mckelligon Brian disposed of 947,688 shares, acquired 724,428 shares and covered exercise/tax liability with 196,866 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Chief Legal Officer Kamocsay Jennifer disposed of 179,272 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- CFO Ek John Frederick disposed of 268,202 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Chief Clinical Officer Bamford Pascal disposed of 205,738 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Director Winkler Matthew disposed of 984,513 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Director Shepler Robert G4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Director Schnettler Thomas P4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Director Raffin Thomas A. disposed of 17,909,839 shares (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Director Lai Goldman Myla disposed of 20,000 shares, closing all direct ownership in the company (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Chief Clinical Officer Bamford Pascal covered exercise/tax liability with 670 shares, decreasing direct ownership by 0.32% to 205,738 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- CFO Ek John Frederick covered exercise/tax liability with 16,432 shares, decreasing direct ownership by 6% to 248,202 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- President and CEO Mckelligon Brian covered exercise/tax liability with 7,550 shares, decreasing direct ownership by 2% to 420,126 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Chief Business Officer Ramachandran Niro Ph.D covered exercise/tax liability with 2,310 shares, decreasing direct ownership by 0.80% to 287,210 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Chief Legal Officer Kamocsay Jennifer covered exercise/tax liability with 7,445 shares, decreasing direct ownership by 4% to 179,272 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- CFO Ek John Frederick covered exercise/tax liability with 3,594 shares, decreasing direct ownership by 1% to 264,634 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Chief Clinical Officer Bamford Pascal covered exercise/tax liability with 3,850 shares, decreasing direct ownership by 2% to 206,408 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Chief Business Officer Ramachandran Niro Ph.D covered exercise/tax liability with 5,904 shares, decreasing direct ownership by 2% to 289,520 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- President and CEO Mckelligon Brian covered exercise/tax liability with 15,807 shares, decreasing direct ownership by 4% to 427,676 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Chief Legal Officer Kamocsay Jennifer was granted 87,500 shares, increasing direct ownership by 88% to 186,717 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- CFO Ek John Frederick was granted 87,500 shares, increasing direct ownership by 48% to 268,228 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Chief Clinical Officer Bamford Pascal was granted 87,500 shares, increasing direct ownership by 71% to 210,258 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Chief Business Officer Ramachandran Niro Ph.D was granted 87,500 shares, increasing direct ownership by 42% to 295,424 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- President and CEO Mckelligon Brian was granted 218,750 shares, increasing direct ownership by 97% to 443,483 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Director Mendel Scott4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Chief Clinical Officer Bamford Pascal was granted 40,000 shares, increasing direct ownership by 48% to 122,758 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- President and CEO Mckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $15,630 worth of shares (7,500 units at $2.08) (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Mckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $15,064 worth of shares (7,500 units at $2.01) (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Raffin Thomas A.4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Shepler Robert G4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Winkler Matthew4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Schnettler Thomas P4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Lai Goldman Myla4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Mendel Scott4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Ek John Frederick covered exercise/tax liability with 14,272 shares, decreasing direct ownership by 7% to 180,728 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Pla Frederic covered exercise/tax liability with 2,006 shares, decreasing direct ownership by 2% to 101,500 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Ramachandran Niro Ph.D covered exercise/tax liability with 2,006 shares, decreasing direct ownership by 0.96% to 207,924 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Mckelligon Brian covered exercise/tax liability with 7,135 shares, decreasing direct ownership by 3% to 224,733 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Mckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $37,243 worth of shares (7,500 units at $4.97) (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Mckelligon Brian sold $37,042 worth of shares (7,500 units at $4.94) and exercised 7,500 shares at a strike of $0.30 (SEC Form 4) (Amendment)4/A - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Mckelligon Brian sold $37,035 worth of shares (7,500 units at $4.94), decreasing direct ownership by 3% to 224,368 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Shepler Robert G gifted 369,592 shares and received a gift of 369,592 shares (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Mckelligon Brian was granted 87,500 shares and covered exercise/tax liability with 8,195 shares, increasing direct ownership by 52% to 231,868 units (SEC Form 4) (Amendment)4/A - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Ek John Frederick was granted 35,000 shares, increasing direct ownership by 22% to 195,000 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Kamocsay Jennifer was granted 35,000 shares and covered exercise/tax liability with 3,283 shares, increasing direct ownership by 47% to 99,217 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Ramachandran Niro Ph.D was granted 35,000 shares and covered exercise/tax liability with 2,305 shares, increasing direct ownership by 18% to 209,930 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Pla Frederic was granted 35,000 shares and covered exercise/tax liability with 2,049 shares, increasing direct ownership by 47% to 103,506 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Mckelligon Brian was granted 87,500 shares and covered exercise/tax liability with 10,244 shares, decreasing direct ownership by 32% to 103,506 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Mckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $33,566 worth of shares (7,500 units at $4.48) (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Mckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $31,871 worth of shares (7,500 units at $4.25) (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Pla Frederic was granted 30,000 shares, increasing direct ownership by 74% to 70,555 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- Kamocsay Jennifer was granted 30,000 shares, increasing direct ownership by 80% to 67,500 units (SEC Form 4)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4: Pla Frederic bought $92,014 worth of shares (20,000 units at $4.60)4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Ek John Frederick4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Lai Goldman Myla4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Mendel Scott4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Winkler Matthew4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Shepler Robert G4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
- SEC Form 4 filed by Raffin Thomas A.4 - Akoya Biosciences, Inc. (0001711933) (Issuer)